Bovine mastitis (subclinical and clinical): benefits and risks of treatment with antibioticsAuthor
| Autor: | Flores Jiménez, Judit, Universitat Autònoma de Barcelona. Facultat de Veterinària |
|---|---|
| Přispěvatelé: | Arboix Arzo, Margarita |
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona |
| Popis: | Póster Mastitis is an inflammatory reaction of the parenchyma of the mammary gland, in response to damage of infectious nature, traumatic or toxic. It's characterized by pathological changes in the mammary gland tissue; and physical, chemical and bacteriological changes in the milk (1). The mastitis is the most common disease of cows and the most important from the economic viewpoint (2). Currently it's believed that some of the pathogens causing mastitis (Staphylococcus and species Streptococcus) show resistance to macrolides, lincosamides and beta-lactam, sensitives to beta-lactamase (3). Such resistance could make the treatments that currently apply for mastitis will are less effective in controlling the disease and as a result could be a lack of efficacy of treatment due to the presence of resistant germs in farms. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|